Avaleht/Aktsiad/CRBP

CRBP

USD

Corbus Pharmaceuticals Holdings Inc. Common Stock

$11.250-0.880 (-7.255%)

Reaalajas hind

Healthcare

Biotehnoloogia

Ameerika Ühendriigid

Hinnagraafik

Loading Chart...

Põhinäitajad

Turunäitajad

Ettevõtte fundamentaalnäitajad

Kauplemisstatistika

Turunäitajad

Avatud

$12.130

Kõrge

$12.168

Madal

$11.230

Maht

0.56M

Ettevõtte fundamentaalnäitajad

Turukapitalisatsioon

191.2M

Tööstusharu

Biotehnoloogia

Riik

United States

Kauplemisstatistika

Keskmine maht

0.27M

Börs

NCM

Valuuta

USD

52 nädala vahemik

Madal $4.64Praegune $11.250Kõrge $20.77

Seotud uudised

31. okt 2025 · 06:40

GlobeNewswire

Corbus Pharmaceuticals Announces Pricing of Public Offering

NORWOOD, Mass., Oct. 31, 2025 (GLOBE NEWSWIRE) -- Corbus Pharmaceuticals Holdings, Inc. (NASDAQ:CRBP) ("Corbus" or the "Company"), an oncology and obesity company, today announced the pricing of an underwritten public

Vaata rohkem

Corbus Pharmaceuticals Announces Pricing of Public Offering

30. okt 2025 · 20:31

GlobeNewswire

Corbus Pharmaceuticals Announces Proposed Public Offering

NORWOOD, Mass., Oct. 30, 2025 (GLOBE NEWSWIRE) -- Corbus Pharmaceuticals Holdings, Inc. (NASDAQ:CRBP) ("Corbus" or the "Company"), an oncology and obesity company, today announced that it plans to offer and sell shares

Vaata rohkem

Corbus Pharmaceuticals Announces Proposed Public Offering

14. okt 2025 · 12:00

GlobeNewswire

Corbus Pharmaceuticals to Present CRB-701 Phase 1/2 Data at ESMO 2025

Data to be presented for 167 enrolled participants of which 122 were evaluable for efficacy Company to host HNSCC KOL event to review and discuss data NORWOOD, Mass., Oct. 14, 2025

Vaata rohkem